跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZEALARGY TABLET 10mg - HSA Drug Approval Details
Approvals
/
HSA
/
ZEALARGY TABLET 10mg
Approved
THERAPEUTIC
ZEALARGY TABLET 10mg
Cadila Pharmaceuticals Limited
🇸🇬 Health Sciences Authority
Approval Date
Oct 3, 2024
Approval ID
ef78f1b3c40d6b2c
Company
Cadila Pharmaceuticals Limited
Type
Therapeutic
Approval Details
Approval Id
ef78f1b3c40d6b2c
Drug Name
ZEALARGY TABLET 10mg
Product Name
ZEALARGY TABLET 10mg
Approval Number
SIN17107P
Approval Date
2024-10-03
Registrant
UNI DRUG HOUSE
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
R06AX28
Pharma Manufacturer Name
UNI DRUG HOUSE SDN. BHD.
Company Detail Path
/organization/uni-drug-house-sdn-bhd
Active Ingredients
Rupatadine Fumarate eq. to Rupatadine 10mg
12.79mg
Rupatadine Fumarate eq. to Rupatadine 10mg
12.79mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 3, 2024
Approval ID
ef78f1b3c40d6b2c
Type
Therapeutic
Back to HSA Approvals